— Know what they know.
Not Investment Advice

HIMS NYSE

Hims & Hers Health, Inc.
1W: -1.4% 1M: +1.1% 3M: -24.2% YTD: -13.2% 1Y: -48.5% 3Y: +366.2% 5Y: +258.0%
$29.00
-0.30 (-1.02%)
 
Weekly Expected Move ±6.4%
$25 $27 $29 $31 $33
NYSE · Healthcare · Medical - Care Facilities · Tech Score Buy · Power 59 · $6.5B mcap · 209M float · 6.86% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
49.2 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -7.1%  ·  5Y Avg: 7.9%
Cost Advantage
27
Intangibles
67
Switching Cost
54
Network Effect
47
Scale
43
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HIMS shows a Weak competitive edge (49.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -7.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$26
Low
$33
Avg Target
$42
High
Based on 5 analysts since Aug 10, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 13Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$33.33
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-24 Truist Financial — $18 $32 +14 +2.4% $31.25
2026-08-20 Barclays Glen Santangelo $39 $35 -4 +6.6% $32.83
2026-08-11 Deutsche Bank George Hill $25 $26 +1 -16.7% $31.23
2026-08-11 Needham Ryan MacDonald $30 $42 +12 +32.2% $31.77
2026-08-11 Morgan Stanley — $21 $28 +7 -11.9% $31.77
2026-07-09 UBS — $25 $37 +12 +2.6% $36.07
2026-07-01 Canaccord Genuity — $32 $40 +8 +15.4% $34.67
2026-06-17 Barclays — $25 $39 +14 +22.3% $31.89
2026-06-02 Leerink Partners Michael Cherny $18 $25 +8 -9.5% $27.64
2026-05-26 UBS — $23 $25 +2 +5.3% $23.75
2026-05-22 UBS — $35 $23 -12 -3.7% $23.88
2026-05-12 Jefferies — $18 $24 +6 -3.1% $25.28
2026-05-12 UBS — $32 $35 +3 +38.8% $25.22
2026-05-12 Canaccord Genuity — $68 $32 -36 +9.8% $29.14
2026-05-05 Deutsche Bank George Hill $28 $25 -3 -4.5% $26.19
2026-03-10 Deutsche Bank — $31 $28 -3 +19.3% $23.47
2026-03-09 Needham Ryan MacDonald $65 $30 -35 +34.2% $22.35
2026-03-09 Oppenheimer — Initiated $12 — -42.1% $21.58
2026-02-24 Barclays — $48 $25 -23 +57.2% $15.90
2026-02-24 Morgan Stanley Craig Hettenbach $40 $21 -19 +46.0% $14.38
2026-02-24 Evercore ISI — Initiated $24 — +70.2% $14.10
2026-02-24 Truist Financial Jailendra Singh $37 $18 -19 +16.1% $15.51
2026-02-24 Leerink Partners — $20 $18 -2 +12.8% $15.51
2026-02-10 Deutsche Bank George Hill $23 $31 +8 +69.8% $18.25
2026-02-09 Leerink Partners Michael Cherny $41 $20 -21 +15.3% $17.35
2026-02-02 BTIG — Initiated $60 — +121.5% $27.09
2026-01-08 Wolfe Research — Initiated $29 — -18.2% $35.46
2025-12-08 Barclays — Initiated $48 — +22.7% $39.12
2025-12-04 Leerink Partners Michael Cherny $46 $41 -5 +1.9% $40.23
2025-11-12 Morgan Stanley Craig Hettenbach Initiated $40 — +0.6% $39.75
2025-11-04 Seaport Global — Initiated $59 — +32.0% $44.71
2025-11-04 Truist Financial Jailendra Singh $45 $37 -8 -17.3% $44.73
2025-11-04 UBS — $30 $32 +2 -27.9% $44.39
2025-11-04 Leerink Partners Michael Cherny $26 $46 +20 +3.6% $44.39
2025-06-24 Truist Financial Jailendra Singh $23 $45 +22 +4.8% $42.95
2025-06-23 UBS — Initiated $30 — -28.5% $41.98
2025-06-04 Needham Ryan Macdonald $28 $65 +37 +21.2% $53.61
2025-02-19 Canaccord Genuity Maria Ripps $38 $68 +30 -1.1% $68.74
2024-12-02 Canaccord Genuity Maria Ripps $24 $38 +14 +23.3% $30.81
2024-11-05 Piper Sandler Korinne Wolfmeyer $13 $21 +8 +1.7% $20.64
2024-11-05 Needham Ryan MacDonald Initiated $28 — +33.6% $20.96
2024-10-29 Leerink Partners Michael Cherny $5 $26 +21 +12.7% $23.08
2024-10-21 Bank of America Securities Michael Cherny $23 $25 +2 +12.9% $22.15
2024-10-14 Bank of America Securities Michael Cherny $20 $23 +3 +16.0% $19.82
2024-10-14 Truist Financial Jailendra Singh $13 $23 +10 +16.0% $19.82
2024-09-13 Bank of America Securities Allen Lutz Initiated $20 — +26.4% $15.82
2024-08-27 Citigroup Daniel Grosslight Initiated $20 — +34.0% $14.93
2024-08-07 Jefferies Glen Santangelo $14 $18 +4 +12.2% $16.04
2024-08-06 Deutsche Bank George Hill $16 $23 +7 +36.3% $16.88
2024-05-22 Canaccord Genuity Maria Ripps $20 $24 +4 +36.7% $17.56

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HIMS receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-06-18 D+ C
2026-05-11 C+ D+
2026-05-04 B- C+
2026-04-01 C+ B-
2026-01-03 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 27 Grade D
Profitability
19
Balance Sheet
50
Earnings Quality
38
Growth
52
Value
23
Momentum
50
Safety
50
Cash Flow
23
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HIMS scores highest in Growth (52/100) and lowest in Profitability (19/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.88
Grey Zone
Piotroski F-Score
4/9
✗ ✓ ✗ ✓ ✓ ✗ ✓ ✗ ✗
Beneish M-Score
34.80
Possible Manipulator
Ohlson O-Score
-4.20
Bankruptcy prob: 1.5%
Low Risk
Credit Rating
BB+
Score: 46.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -1.88x
Accruals: -14.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HIMS scores 1.88, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HIMS scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HIMS's score of 34.80 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HIMS's implied 1.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HIMS receives an estimated rating of BB+ (score: 46.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-47.54x
PEG
1.13x
P/S
2.51x
P/B
20.74x
P/FCF
89.39x
P/OCF
30.11x
EV/EBITDA
-114.37x
EV/Revenue
3.39x
EV/EBIT
-53.42x
EV/FCF
97.23x
Earnings Yield
-1.77%
FCF Yield
1.12%
Shareholder Yield
1.41%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. HIMS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.868
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
-0.063
EBIT / Rev
×
Asset Turnover
0.936
Rev / Assets
×
Equity Multiplier
6.210
Assets / Equity
=
ROE
-32.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HIMS's ROE of -32.0% is driven by financial leverage (equity multiplier: 6.21x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1773 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$29.00
Median 1Y
$25.31
5th Pctile
$7.25
95th Pctile
$88.05
Ann. Volatility
76.9%
Analyst Target
$33.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mr. Elshenawy Technology
nology Officer
$375,000 $57,216,276 $60,869,746
Mr. Dudum
Chief Executive Officer and Chairman
$494,792 $10,635,352 $22,958,907
Mr. Kabbani Operating
ief Operating Officer
$227,273 $13,486,199 $14,862,305
Mr. Okupe Financial
ancial Officer
$530,875 $7,473,689 $8,398,808
Ms. Baird Operating
ief Operating Officer
$341,292 $8,048,579 $8,392,871
Mr. Chi Operating
rating Officer (previously Chief Commercial Officer)
$485,000 $6,898,799 $7,727,713
Ms. Boughton Legal
Legal Officer
$464,375 $4,024,269 $4,796,709

CEO Pay Ratio

47:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $22,958,907
Avg Employee Cost (SGA/emp): $488,133
Employees: 2,442

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,442
+49.2% YoY
Revenue / Employee
$961,358
Rev: $2,347,637,000
Profit / Employee
$52,566
NI: $128,365,000
SGA / Employee
$488,133
Avg labor cost proxy
R&D / Employee
$61,139
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -77.2% -1.1% -23.4% -27.1% -25.8% -20.3% -18.6% -14.7% -11.2% -7.2% -0.7% 5.3% 26.3% 30.7% 36.8% 41.9% 26.2% 25.2% -2.7% -32.0% -32.03%
ROA -30.3% -39.9% -19.9% -22.8% -21.4% -16.7% -15.7% -12.2% -9.0% -5.8% -0.6% 4.2% 19.9% 21.9% 24.5% 16.4% 9.4% 9.0% -0.8% -5.2% -5.16%
ROIC -75.4% -97.9% -50.8% -52.9% -52.6% -39.5% -37.4% -31.2% -26.6% -17.5% 24.9% 7.0% 42.7% 57.9% 52.0% 37.8% 11.3% 8.9% 3.0% -7.1% -7.11%
ROCE -26.1% -36.5% -28.0% -29.6% -28.0% -21.6% -19.7% -16.1% -12.3% -8.4% -2.3% 3.2% 9.5% 12.7% 18.0% 7.8% 6.5% 6.6% -2.7% -7.6% -7.63%
Gross Margin 74.0% 73.3% 73.8% 76.8% 79.0% 79.1% 80.4% 81.8% 82.6% 82.7% 82.4% 81.3% 79.2% 76.8% 73.5% 76.4% 73.8% 71.9% 49.4% 63.8% 63.83%
Operating Margin -37.3% -25.5% -16.7% -17.8% -13.8% -6.9% -5.9% -4.4% -3.8% -0.2% 3.6% 3.5% 5.6% 3.9% 9.9% 4.9% 2.0% 1.5% -2.7% -12.9% -12.90%
Net Margin -21.5% -36.8% -16.0% -17.3% -13.0% -6.5% -5.3% -3.4% -3.3% 0.5% 4.0% 4.2% 18.8% 5.4% 8.4% 7.8% 2.6% 3.3% -15.1% -11.5% -11.46%
EBITDA Margin -35.2% -35.0% -15.0% -16.2% -12.5% -5.7% -4.8% -3.3% -2.7% 0.9% 4.6% 4.6% 6.7% 5.1% 11.3% 6.8% 5.0% 5.9% -13.1% -8.4% -8.38%
FCF Margin -15.9% -14.5% -13.5% -13.5% -6.5% -6.4% -1.0% 1.6% 3.4% 5.4% 5.4% 8.4% 12.0% 13.4% 13.3% 5.9% 5.9% 3.1% 3.2% 3.5% 3.49%
OCF Margin -13.8% -12.7% -11.8% -12.0% -5.2% -5.0% 0.4% 3.6% 5.7% 8.4% 9.4% 11.9% 15.0% 17.0% 18.7% 13.0% 14.7% 12.9% 12.0% 10.4% 10.35%
ROE 3Y Avg snapshot only -1.47%
ROE 5Y Avg snapshot only -9.02%
ROA 3Y Avg snapshot only 3.39%
ROIC Economic snapshot only -4.03%
Cash ROA snapshot only 7.35%
Cash ROIC snapshot only 25.93%
CROIC snapshot only 8.73%
NOPAT Margin snapshot only -2.84%
Pretax Margin snapshot only -6.35%
R&D / Revenue snapshot only 4.98%
SGA / Revenue snapshot only 53.77%
SBC / Revenue snapshot only 5.96%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -18.46 -12.25 -14.90 -11.13 -13.33 -20.12 -34.54 -41.71 -37.03 -79.28 -1509.26 261.86 42.76 46.18 44.33 66.12 105.43 62.76 -358.19 -56.57 -47.541
P/S Ratio 6.60 4.85 3.37 2.47 2.58 2.51 3.33 2.76 1.67 2.14 3.70 4.44 3.49 3.94 4.08 6.36 6.38 3.43 2.00 3.12 2.509
P/B Ratio 4.25 3.94 3.30 2.90 3.68 4.24 6.57 6.12 4.02 5.43 10.30 13.10 9.84 12.21 13.27 22.75 24.28 14.89 10.63 24.79 20.738
P/FCF -41.45 -33.46 -24.91 -18.26 -39.44 -39.12 -336.58 168.50 49.18 39.72 68.37 52.96 28.94 29.35 30.81 107.11 107.23 110.57 62.51 89.39 89.388
P/OCF — — — — — — 872.54 76.61 29.52 25.40 39.50 37.44 23.19 23.18 21.80 48.93 43.39 26.55 16.71 30.11 30.110
EV/EBITDA -13.50 -8.93 -10.05 -8.22 -11.72 -18.74 -33.98 -40.55 -35.04 -83.04 1589.25 191.36 72.22 70.03 53.14 82.06 92.41 51.51 214.06 -114.37 -114.370
EV/Revenue 5.49 3.96 2.75 1.96 2.14 2.18 3.04 2.49 1.41 1.90 3.50 4.24 3.29 3.75 3.94 6.31 6.60 3.72 2.16 3.39 3.390
EV/EBIT -13.10 -8.64 -9.46 -7.64 -10.78 -16.70 -29.75 -34.00 -27.40 -56.21 -405.03 377.71 95.26 89.36 63.95 101.12 126.41 75.89 -115.74 -53.42 -53.419
EV/FCF -34.52 -27.33 -20.35 -14.50 -32.80 -33.96 -307.18 152.33 41.45 35.23 64.67 50.55 27.32 27.89 29.72 106.27 110.94 119.99 67.54 97.23 97.233
Earnings Yield -5.4% -8.2% -6.7% -9.0% -7.5% -5.0% -2.9% -2.4% -2.7% -1.3% -0.1% 0.4% 2.3% 2.2% 2.3% 1.5% 0.9% 1.6% -0.3% -1.8% -1.77%
FCF Yield -2.4% -3.0% -4.0% -5.5% -2.5% -2.6% -0.3% 0.6% 2.0% 2.5% 1.5% 1.9% 3.5% 3.4% 3.2% 0.9% 0.9% 0.9% 1.6% 1.1% 1.12%
PEG Ratio snapshot only 1.131
EV/OCF snapshot only 32.753
EV/Gross Profit snapshot only 5.241
Shareholder Yield snapshot only 1.41%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 5.22 3.41 4.78 4.14 3.49 4.52 4.01 3.53 3.03 3.00 2.80 2.68 2.14 1.79 1.59 4.98 1.88 1.90 1.69 0.93 0.934
Quick Ratio 5.02 3.24 4.53 3.79 3.16 4.07 3.64 3.20 2.76 2.74 2.48 2.30 1.82 1.50 1.32 4.46 1.64 1.61 1.55 0.87 0.874
Debt/Equity 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.03 0.03 0.03 0.02 0.12 1.86 1.92 2.34 2.54 4.77 4.771
Net Debt/Equity -0.71 -0.72 -0.60 -0.60 -0.62 -0.56 -0.57 -0.59 -0.63 -0.61 -0.56 -0.60 -0.55 -0.61 -0.47 -0.18 0.84 1.27 0.85 2.18 2.176
Debt/Assets 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.03 0.02 0.02 0.02 0.07 0.56 0.50 0.59 0.50 0.43 0.426
Debt/EBITDA -0.00 -0.05 -0.06 -0.05 -0.07 -0.09 -0.09 -0.12 -0.15 -0.50 5.60 0.49 0.20 0.14 0.48 6.75 7.08 7.45 47.31 -20.23 -20.234
Net Debt/EBITDA 2.71 2.00 2.25 2.13 2.37 2.85 3.25 4.31 6.54 10.58 -90.80 -9.13 -4.29 -3.66 -1.96 -0.65 3.09 4.04 15.93 -9.23 -9.228
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.18 1.26 1.17 1.19 1.23 1.18 1.20 1.22 1.26 1.28 1.30 1.33 1.37 1.48 1.62 3.34 3.84 3.98 5.08 11.20 11.198
Cash Ratio snapshot only 0.567
Cash to Debt snapshot only 0.544
FCF to Debt snapshot only 0.058
Defensive Interval snapshot only 252.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.85 1.01 0.88 1.03 1.11 1.34 1.63 1.85 1.99 2.16 2.33 2.45 2.44 2.57 2.66 1.71 1.56 1.64 1.50 0.94 0.936
Inventory Turnover 6.88 7.88 9.83 7.22 6.38 6.73 7.86 6.83 6.74 7.13 6.68 6.13 6.59 6.98 7.73 5.26 7.12 6.82 9.54 7.93 7.932
Receivables Turnover 176.49 125.67 100.20 120.92 173.16 154.79 124.04 160.83 197.21 174.77 176.36 225.78 282.18 230.20 267.34 327.78 96.33 122.82 30.27 13.50 13.497
Payables Turnover 4.77 4.86 4.41 4.45 4.32 4.55 4.19 4.29 3.98 4.16 4.14 3.99 3.99 4.52 5.36 5.91 4.03 5.24 3.69 3.00 3.004
DSO 2 3 4 3 2 2 3 2 2 2 2 2 1 2 1 1 4 3 12 27 27.0 days
DIO 53 46 37 51 57 54 46 53 54 51 55 60 55 52 47 69 51 54 38 46 46.0 days
DPO 77 75 83 82 85 80 87 85 92 88 88 92 91 81 68 62 90 70 99 122 121.5 days
Cash Conversion Cycle -21 -26 -42 -29 -25 -24 -38 -29 -36 -34 -31 -30 -35 -27 -20 9 -35 -13 -49 -48 -48.5 days
Fixed Asset Turnover snapshot only 4.866
Operating Cycle snapshot only 73.1 days
Cash Velocity snapshot only 3.065
Capital Intensity snapshot only 1.408
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 73.1% 82.8% 87.6% 90.9% 94.4% 93.8% 92.1% 90.2% 78.3% 65.5% 55.7% 50.1% 56.7% 69.3% 86.0% 88.7% 78.0% 59.0% 32.8% 28.0% 28.04%
Net Income -2.2% -4.9% -14.2% -15.9% -5.1% 39.0% 17.9% 43.4% 58.5% 64.1% 96.0% 1.4% 3.8% 6.4% 70.9% 9.7% 32.1% 1.8% -1.1% -1.7% -1.73%
EPS 42.4% -1.3% 13.7% -9.0% -2.5% 40.4% 19.7% 44.6% 59.4% 64.8% 96.4% 1.3% 3.5% 5.7% 66.0% 8.8% 24.9% -1.2% -1.1% -1.8% -1.81%
FCF -1.3% -4.9% -1.5% -2.0% 20.2% 14.3% 85.9% 1.2% 1.9% 2.4% 9.5% 6.7% 4.6% 3.2% 3.6% 33.5% -12.1% -63.3% -67.9% -24.8% -24.79%
EBITDA -2.8% -7.6% -56.0% -23.2% 12.7% 49.3% 37.1% 51.1% 60.9% 67.4% 1.0% 1.5% 2.8% 5.0% 61.6% 5.5% 1.8% 1.1% -81.9% -1.5% -1.49%
Op. Income -3.1% -6.6% -45.7% -17.0% 19.8% 40.3% 24.5% 39.7% 48.3% 57.1% 86.9% 1.2% 2.1% 3.1% 14.3% 9.5% 1.7% 70.6% -71.6% -1.7% -1.74%
OCF Growth snapshot only 1.99%
Asset Growth snapshot only 93.27%
Equity Growth snapshot only -42.41%
Debt Growth snapshot only 48.05%
Shares Change snapshot only -9.75%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — 1.8% 1.2% 98.6% 81.7% 80.3% 77.7% 76.0% 75.8% 75.8% 77.2% 75.3% 70.7% 64.5% 56.7% 53.7% 53.65%
Revenue 5Y — — — — — — — — — — — — — 1.3% 1.0% 85.9% 75.7% 73.6% 69.2% 67.5% 67.46%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — 2.0% 1.4% 1.1% 90.7% 86.9% 83.0% 79.9% 79.5% 79.0% 79.2% 76.5% 69.8% 61.9% 48.7% 43.0% 42.99%
Gross Profit 5Y — — — — — — — — — — — — — 1.4% 1.1% 90.3% 78.0% 73.8% 65.5% 61.7% 61.73%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — 97.7% 97.73%
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — 3.9% 1.2% 1.19%
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — 71.9% 73.5% 55.1% 51.4% 54.9% 9.0% 11.4% 12.8% 18.9% 32.6% 70.3% 80.0% 80.5% 82.0% 1.1% 1.10%
Assets 5Y — — — — — — — — — — — — — 57.9% 65.4% 78.2% 79.7% 78.6% 45.6% 59.8% 59.85%
Equity 3Y — — — — — — — 53.1% — — 5.6% 7.3% 7.4% 12.5% 18.8% 20.8% 23.2% 20.2% 12.6% 0.4% 0.41%
Book Value 3Y — — — — — — — -15.3% — — -7.7% 0.3% 1.8% 6.0% 11.3% 11.9% 15.5% 13.0% 9.0% -3.1% -3.07%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — 1.00 0.99 0.98 0.95 0.96 0.95 0.94 0.94 0.96 0.97 0.98 0.98 0.89 0.86 0.85 0.86 0.89 0.92 0.93 0.927
Earnings Stability — 0.80 0.87 0.88 0.80 0.52 0.51 0.19 0.02 0.07 0.03 0.15 0.39 0.24 0.44 0.51 0.63 0.64 0.37 0.06 0.061
Margin Stability — 0.89 0.92 0.93 0.95 0.90 0.92 0.93 0.94 0.95 0.95 0.96 0.96 0.89 0.91 0.93 0.94 0.95 0.93 0.91 0.910
Rev. Growth Consistency 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — 0.50 0.94 0.94 0.98 0.84 0.93 0.83 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — 0.00 0.72 0.98 — — —
ROE Trend — — — -0.03 — — 0.03 0.11 0.14 0.20 0.20 0.25 0.42 0.40 0.40 0.39 0.17 0.14 -0.18 -0.64 -0.635
Gross Margin Trend — 0.08 0.04 0.02 0.03 0.03 0.04 0.04 0.05 0.06 0.06 0.05 0.02 -0.00 -0.04 -0.05 -0.06 -0.07 -0.12 -0.15 -0.145
FCF Margin Trend — 0.10 0.07 0.01 0.08 0.03 0.11 0.13 0.15 0.16 0.13 0.14 0.14 0.14 0.11 0.01 -0.02 -0.06 -0.06 -0.04 -0.037
Sustainable Growth Rate — — — — — — — — — — — 5.3% 26.3% 30.7% 36.8% 41.9% 26.2% 25.2% — — —
Internal Growth Rate — — — — — — — — — — — 4.3% 24.9% 28.1% 32.5% 19.6% 10.4% 9.9% — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.39 0.32 0.52 0.54 0.27 0.40 -0.04 -0.54 -1.25 -3.12 -38.21 6.99 1.84 1.99 2.03 1.35 2.43 2.36 -21.43 -1.88 -1.879
FCF/OCF 1.15 1.15 1.15 1.13 1.27 1.27 -2.59 0.45 0.60 0.64 0.58 0.71 0.80 0.79 0.71 0.46 0.40 0.24 0.27 0.34 0.337
FCF/Net Income snapshot only -0.633
CapEx/Revenue 2.1% 1.8% 1.7% 1.5% 1.4% 1.4% 1.4% 2.0% 2.3% 3.0% 4.0% 3.5% 3.0% 3.6% 5.5% 7.1% 8.8% 9.8% 8.8% 6.9% 6.86%
CapEx/Depreciation snapshot only 2.030
Accruals Ratio -0.19 -0.27 -0.10 -0.10 -0.16 -0.10 -0.16 -0.19 -0.20 -0.24 -0.22 -0.25 -0.17 -0.22 -0.25 -0.06 -0.13 -0.12 -0.19 -0.15 -0.149
Sloan Accruals snapshot only -0.461
Cash Flow Adequacy snapshot only 1.508
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — —
FCF Payout Ratio — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — 2.7% 77.1% 65.9% 33.4% 18.1% 10.8% 70.1% — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 1.5% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.0% 1.8% 1.4% 0.8% 0.3% 0.1% 1.1% 1.9% 1.4% 1.41%
Net Buyback Yield -16.6% -19.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.0% 1.8% 1.4% 0.8% 0.2% -0.0% 0.8% 1.3% 1.0% 0.98%
Total Shareholder Return -16.6% -19.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.0% 1.8% 1.4% 0.8% 0.2% -0.0% 0.8% 1.3% 1.0% 0.98%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.96 0.97 0.96 0.96 1.00 1.00 1.00 1.01 1.03 1.09 -4.58 0.86 1.96 1.76 1.37 1.39 1.05 1.04 0.35 0.87 0.868
Interest Burden (EBT/EBIT) 0.88 0.89 0.81 0.90 0.97 0.96 0.94 0.90 0.86 0.73 -0.06 1.76 1.20 1.16 1.09 1.11 1.11 1.08 0.86 1.00 1.000
EBIT Margin -0.42 -0.46 -0.29 -0.26 -0.20 -0.13 -0.10 -0.07 -0.05 -0.03 -0.01 0.01 0.03 0.04 0.06 0.06 0.05 0.05 -0.02 -0.06 -0.063
Asset Turnover 0.85 1.01 0.88 1.03 1.11 1.34 1.63 1.85 1.99 2.16 2.33 2.45 2.44 2.57 2.66 1.71 1.56 1.64 1.50 0.94 0.936
Equity Multiplier 2.55 2.87 1.17 1.19 1.21 1.22 1.18 1.20 1.25 1.23 1.25 1.28 1.32 1.40 1.50 2.55 2.78 2.81 3.17 6.21 6.210
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.41 $-0.53 $-0.36 $-0.41 $-0.42 $-0.32 $-0.29 $-0.23 $-0.17 $-0.11 $-0.01 $0.08 $0.43 $0.52 $0.67 $0.75 $0.54 $0.52 $-0.06 $-0.61 $-0.61
Book Value/Share $1.78 $1.66 $1.62 $1.56 $1.52 $1.51 $1.51 $1.54 $1.56 $1.64 $1.50 $1.54 $1.87 $1.98 $2.23 $2.19 $2.34 $2.18 $1.95 $1.40 $1.40
Tangible Book/Share $1.09 $0.98 $0.95 $0.90 $0.87 $0.87 $0.87 $0.91 $0.94 $1.02 $0.94 $1.00 $1.20 $1.33 $1.57 $1.57 $0.51 $0.27 $-0.69 $-5.18 $-5.18
Revenue/Share $1.14 $1.35 $1.58 $1.83 $2.17 $2.56 $2.98 $3.41 $3.77 $4.16 $4.18 $4.55 $5.28 $6.13 $7.24 $7.84 $8.89 $9.46 $10.38 $11.12 $11.12
FCF/Share $-0.18 $-0.20 $-0.21 $-0.25 $-0.14 $-0.16 $-0.03 $0.06 $0.13 $0.22 $0.23 $0.38 $0.64 $0.82 $0.96 $0.47 $0.53 $0.29 $0.33 $0.39 $0.39
OCF/Share $-0.16 $-0.17 $-0.19 $-0.22 $-0.11 $-0.13 $0.01 $0.12 $0.21 $0.35 $0.39 $0.54 $0.79 $1.04 $1.36 $1.02 $1.31 $1.22 $1.24 $1.15 $1.15
Cash/Share $1.26 $1.23 $1.00 $0.96 $0.97 $0.87 $0.89 $0.93 $1.01 $1.05 $0.89 $0.97 $1.08 $1.25 $1.31 $4.46 $2.53 $2.33 $3.29 $3.63 $3.63
EBITDA/Share $-0.47 $-0.60 $-0.43 $-0.44 $-0.40 $-0.30 $-0.27 $-0.21 $-0.15 $-0.10 $0.01 $0.10 $0.24 $0.33 $0.54 $0.60 $0.64 $0.68 $0.10 $-0.33 $-0.33
Debt/Share $0.00 $0.03 $0.03 $0.02 $0.03 $0.03 $0.02 $0.02 $0.02 $0.05 $0.05 $0.05 $0.05 $0.05 $0.26 $4.07 $4.50 $5.09 $4.96 $6.67 $6.67
Net Debt/Share $-1.26 $-1.20 $-0.98 $-0.93 $-0.94 $-0.85 $-0.87 $-0.90 $-0.99 $-1.01 $-0.84 $-0.92 $-1.03 $-1.20 $-1.05 $-0.39 $1.96 $2.77 $1.67 $3.04 $3.04
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.875
Altman Z-Prime snapshot only 1.809
Piotroski F-Score 1 1 2 2 3 5 6 5 6 5 5 5 5 6 5 5 3 4 4 4 4
Beneish M-Score -1.52 1.57 8.84 3.26 -1.95 -2.65 -3.02 -3.14 -3.20 -2.71 -3.09 -3.17 -2.61 -2.75 -2.62 -2.19 2.60 0.70 15.67 34.80 34.803
Ohlson O-Score snapshot only -4.202
Net-Net WC snapshot only $-8.29
EVA snapshot only $-176134020.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 89.00 73.06 72.95 73.98 73.59 74.37 76.66 80.58 80.04 80.65 73.58 93.39 93.26 93.66 93.60 79.79 75.99 72.79 61.60 46.03 46.028
Credit Grade snapshot only 11
Credit Trend snapshot only -33.762
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms